David M Cohen
Overview
Explore the profile of David M Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1341
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sterns R, Rondon-Berrios H, Adrogue H, Berl T, Burst V, Cohen D, et al.
Clin J Am Soc Nephrol
. 2023 Jun;
19(1):129-135.
PMID: 37379081
International guidelines designed to minimize the risk of complications that can occur when correcting severe hyponatremia have been widely accepted for a decade. On the basis of the results of...
2.
Tran K, Harrod C, Bourdette D, Cohen D, Deodhar A, Hartung D
JAMA Intern Med
. 2021 Dec;
182(2):206-217.
PMID: 34902005
Importance: Repository corticotropin injection is an expensive medication that was approved in 1952 for the treatment of many inflammatory conditions. The clinical evidence supporting the use of repository corticotropin (hereinafter...
3.
Hartung D, Cohen D, Deodhar A, Bourdette D
Ann Intern Med
. 2019 Oct;
171(8):601-602.
PMID: 31610564
No abstract available.
4.
Timmons A, Korpak A, Tan J, Moore K, Liu C, Forsberg C, et al.
Am J Physiol Renal Physiol
. 2019 Mar;
316(6):F1114-F1123.
PMID: 30908934
Little is known about the population genetics of water balance. A recent meta-genome-wide association study on plasma sodium concentration identified novel loci of high biological plausibility, yet heritability of the...
5.
Hartung D, Johnston K, Deodhar A, Bourdette D, Cohen D
Am J Kidney Dis
. 2019 Feb;
74(2):256-262.
PMID: 30765104
Despite little evidence supporting its superiority to glucocorticoid therapy, use and expenditures for repository corticotropin (rACTH) injection (H.P. Acthar Gel; Mallinckrodt) have increased dramatically in the last 5 years, particularly...
6.
Bosch N, Cohen D, Walkey A
Crit Care Med
. 2019 Jan;
47(2):280-287.
PMID: 30653473
Objective: Atrial fibrillation frequently develops in patients with sepsis and is associated with increased morbidity and mortality. Unfortunately, risk factors for new-onset atrial fibrillation in sepsis have not been clearly...
7.
Hartung D, Johnston K, Cohen D, Nguyen T, Deodhar A, Bourdette D
JAMA Netw Open
. 2019 Jan;
1(2):e180482.
PMID: 30646086
Importance: Despite great expense and little evidence supporting use over corticosteroids, prescriptions for repository corticotropin (H. P. Acthar Gel; Mallinckrodt Pharmaceuticals) have increased markedly. Aggressive sales tactics and payments from...
8.
Hartung D, Bourdette D, Cohen D
JAMA Intern Med
. 2018 Apr;
178(4):583-584.
PMID: 29610884
No abstract available.
9.
Hartung D, Johnston K, Cohen D, Nguyen T, Deodhar A, Bourdette D
Ann Rheum Dis
. 2018 Jan;
78(2):e11.
PMID: 29363509
No abstract available.
10.
Cohen D, Winter M, Lindenauer P, Walkey A
Ann Am Thorac Soc
. 2018 Jan;
15(5):581-588.
PMID: 29298088
Rationale: Societal guideline recommendations vary with regard to the role of routine trans-thoracic echocardiography to screen for right ventricular strain in patients with hemodynamically stable acute pulmonary embolism. Objective: To...